(Q34219361)

31 July 2017

1 reference

title

Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome (English)

1 reference

31 July 2017

author name string

Andrew S Papadopoulos

series ordinal

1

1 reference

31 July 2017

Anthony J Cleare

series ordinal

2

1 reference

31 July 2017

publication date

27 September 2011

1 reference

Nature Reviews Endocrinology

31 July 2017

published in

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

22-32

1 reference

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Chronic fatigue syndrome: an update focusing on phenomenology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The neuroendocrinology of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The HPA axis and the genesis of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Salivary cortisol response to awakening in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The effects of galantamine hydrobromide treatment on dehydroepiandrosterone sulfate and cortisol levels in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: an experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The cortisol response to awakening in relation to different challenge tests and a 12-hour cortisol rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Attenuated morning salivary cortisol concentrations in a population-based study of persons with chronic fatigue syndrome and well controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Childhood trauma and risk for chronic fatigue syndrome: association with neuroendocrine dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Low-dose dexamethasone suppression test in chronic fatigue syndrome and health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Burnout, perceived stress, and cortisol responses to awakening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Basal cortisol, dexamethasone suppression of cortisol, and MHPG in adolescents after the 1988 earthquake in Armenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Increased sensitivity to glucocorticoids in peripheral blood mononuclear cells of chronic fatigue syndrome patients, without evidence for altered density or affinity of glucocorticoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Plasma leptin in chronic fatigue syndrome and a placebo-controlled study of the effects of low-dose hydrocortisone on leptin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

DHEA and DHEA-S: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

24-Hour Secretory Pattern of Dehydroisoandrosterone and Dehydroisoandrosterone Sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Influence of DHEA administration on 24-hour cortisol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Methodological challenges in the evaluation of prognostic factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Predictors of fatigue following the onset of infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Salivary cortisol as a predictor of postoperative fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

A new view on hypocortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Hypoglycemia in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Hair as a retrospective calendar of cortisol production-Increased cortisol incorporation into hair in the third trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Hair analysis provides a historical record of cortisol levels in Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Higher cortisol content in hair among long-term unemployed individuals compared to controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Decreased hair cortisol concentrations in generalised anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

An assessment of cortisol analysis in hair and its clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Stress, cognitive impairment and cell adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Free Cortisol Levels after Awakening: A Reliable Biological Marker for the Assessment of Adrenocortical Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Enhanced glucocorticoid sensitivity in patients with chronic fatigue syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Dehydroepiandrosterone (DHEA): a fountain of youth?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Relationship of dehydroepiandrosterone and cortisol in disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Adrenal steroid secretion and major depression in 8- to 16-year-olds, III. Influence of cortisol/DHEA ratio at presentation on subsequent rates of disappointing life events and persistent major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Evaluation of a method to measure long term cortisol levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.153

Decreased dehydroepiandrosterone sulfate but normal insulin-like growth factor in chronic fatigue syndrome (CFS): relevance for the inflammatory response in CFS.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21946893

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Measuring cortisol and DHEA in fingernails: a pilot study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21946893

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2011.153

1 reference

31 July 2017

1 reference